Correlation Between HCW Biologics and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Elevation Oncology, you can compare the effects of market volatilities on HCW Biologics and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Elevation Oncology.
Diversification Opportunities for HCW Biologics and Elevation Oncology
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Elevation is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of HCW Biologics i.e., HCW Biologics and Elevation Oncology go up and down completely randomly.
Pair Corralation between HCW Biologics and Elevation Oncology
Given the investment horizon of 90 days HCW Biologics is expected to generate 13.07 times more return on investment than Elevation Oncology. However, HCW Biologics is 13.07 times more volatile than Elevation Oncology. It trades about 0.13 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.07 per unit of risk. If you would invest 44.00 in HCW Biologics on August 30, 2024 and sell it today you would earn a total of 6.21 from holding HCW Biologics or generate 14.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Elevation Oncology
Performance |
| Timeline |
| HCW Biologics |
| Elevation Oncology |
HCW Biologics and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Elevation Oncology
The main advantage of trading using opposite HCW Biologics and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Elevation Oncology vs. Bright Minds Biosciences | Elevation Oncology vs. HP Inc | Elevation Oncology vs. Intel | Elevation Oncology vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |